TheraRadar
Clinical-Stage Companies / Ache Laboratorios Farmaceuticos

Ache Laboratorios Farmaceuticos

Pre-Approval PRO BETA
27
Total Trials
23
Phase 3
1
Phase 2
0
Recruiting
364
Score

Pipeline by Phase

Phase 3
23
Phase 2
1
Phase 1
2

Therapeutic Focus

Migraine Cough Rhinitis Asthma Nasal Congestion and Inflammations

Clinical Trials (27)

NCT07270432 Phase 3 NOT YET RECRUITING

Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

Started: 1/1/2026

NCT06577077 Phase 3 NOT YET RECRUITING

Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

Started: 9/1/2024

NCT02582177 Phase 3 COMPLETED

Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis

Started: 6/11/2019

NCT01420549 Phase 3 COMPLETED

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Started: 3/1/2013

NCT02904304 Phase 3 SUSPENDED

Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu

Started: 12/1/2020

NCT02853578 Phase 3 SUSPENDED

Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled

Started: 12/1/2019

NCT03508167 Phase 3 WITHDRAWN

Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.

Started: 1/1/2020

NCT02582996 Phase 3 SUSPENDED

Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks

Started: 4/1/2020

NCT02706015 Phase 3 WITHDRAWN

Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks

Started: 10/1/2020

NCT02581397 Phase 3 TERMINATED

Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough

Started: 5/5/2015

NCT01199497 Phase 3 WITHDRAWN

Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis

Started: 8/1/2011

NCT01393145 Phase 3 WITHDRAWN

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Started: 8/1/2011

NCT01393548 Phase 3 COMPLETED

Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis

Started: 8/1/2014

NCT01393561 Phase 3 COMPLETED

Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis

Started: 7/1/2014

NCT01392768 Phase 3 COMPLETED

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Started: 1/1/2013

NCT01390324 Phase 3 WITHDRAWN

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

Started: 12/1/2011

NCT01177852 Phase 3 WITHDRAWN

Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

Started: 10/1/2011

NCT01695616 Phase 3 WITHDRAWN

Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms

Started: 8/1/2013

NCT02713139 Phase 3 WITHDRAWN

Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.

Started: 9/1/2013

NCT01726920 Phase 3 WITHDRAWN

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Started: 7/1/2014

NCT01419964 Phase 3 WITHDRAWN

Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Started: 1/1/2012

NCT02010918 Phase 3 COMPLETED

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

Started: 2/1/2009

NCT01676987 Phase 3 COMPLETED

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Started: 4/1/2009

NCT04487860 Phase 2 COMPLETED

Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo

Started: 1/13/2021

NCT02949089 Phase 1 COMPLETED

ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

Started: 1/1/2013

NCT01702675 Phase 1 TERMINATED

Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug

Started: 5/1/2015

NCT02409381 Phase 4 COMPLETED

Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis

Started: 6/1/2015

Drug Candidates

Product DNN.65.21.005 Combodart® AS012 Placebo Product CM9241GRU Candicort® Nizoral® Baycuten N® Canesten® Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
Activity Status: Active
Last Trial Started: 1/1/2026
Last Trial Ended: 2/27/2023
Trials (12 months): 1
Completed Trials: 10
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.